Sharp Shalini
SEC insider (Form 3/4/5 filer). CIK 0001377202. Director at Iambic Therapeutics, Inc. (IAM) and 4 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in SAN DIEGO, CA.
Companies Sharp Shalini has filed insider reports for
- Iambic Therapeutics, Inc. (IAM): Director
- BeOne Medicines Ltd. (ONC): Director
- Organon & Co. (OGN): Director
- NEUROCRINE BIOSCIENCES INC (NBIX): Director
- Septerna, Inc. (SEPN): Director
Sharp Shalini
CIK: 0001377202
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Oct 14, 2026IAM
Iambic Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20.3K shares- - Jun 12, 2026OGN
Organon & Co.
AwardDirectPhantom Stock
17.9K shares at avg. $13.44- - Jun 11, 2026ONC
BeOne Medicines Ltd.
AwardDirect19K shares- - May 27, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectRestriced Stock Unit
2.6K shares- - May 21, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect1.7K shares- - Jun 17, 2025SEPN
Septerna, Inc.
AwardDirectStock Option (Right to Buy)
16.6K shares- - Jun 13, 2025OGN
Organon & Co.
AwardDirectPhantom Stock
23.9K shares at avg. $10.04- - May 22, 2025NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect1.4K shares- - May 21, 2025BGNE
BeiGene, Ltd.
AwardDirect11K shares- - May 21, 2025NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectRestricted Stock Unit
1.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 14, 2026 |  IAM Iambic Therapeutics, Inc. | Award Stock Option (right to buy) | 20,300 | - | - | Direct |
| Jun 12, 2026 |  OGN Organon & Co. | Award Phantom Stock | 17,857 | $13.44 | - | Direct |
| Jun 11, 2026 |  ONC BeOne Medicines Ltd. | Award | 18,980 | - | $0 | Direct |
| May 27, 2026 |  NBIX NEUROCRINE BIOSCIENCES INC | Award Restriced Stock Unit | 2,567 | - | - | Direct |
| May 21, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 1,659 | - | $0 | Direct |
| Jun 17, 2025 |  SEPN Septerna, Inc. | Award Stock Option (Right to Buy) | 16,623 | - | - | Direct |
| Jun 13, 2025 | OGN Organon & Co. | Award Phantom Stock | 23,904 | $10.04 | - | Direct |
| May 22, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 1,435 | - | - | Direct |
| May 21, 2025 |  BGNE BeiGene, Ltd. | Award | 10,985 | - | - | Direct |
| May 21, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Award Restricted Stock Unit | 1,659 | - | - | Direct |
1-10 of 12 transactions